Post-proteasomal antigen processing for major histocompatibility complex class I presentation.
about
Unanticipated antigens: translation initiation at CUG with leucineMechanisms of HIV protein degradation into epitopes: implications for vaccine designThe Exquisite Structure and Reaction Mechanism of Bacterial Pz-peptidase A toward Collagenous Peptides: X-RAY CRYSTALLOGRAPHIC STRUCTURE ANALYSIS OF PZ-PEPTIDASE A REVEALS DIFFERENCES FROM MAMMALIAN THIMET OLIGOPEPTIDASEStructural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1Structural insights into the molecular ruler mechanism of the endoplasmic reticulum aminopeptidase ERAP1Structure characterization of the 26S proteasome.Heteromeric protein complexes mediate zinc transport into the secretory pathway of eukaryotic cells.ERAAP synergizes with MHC class I molecules to make the final cut in the antigenic peptide precursors in the endoplasmic reticulumRegulation of CD8+ T cell development by thymus-specific proteasomesProteasome assemblyPuromycin-sensitive aminopeptidase is the major peptidase responsible for digesting polyglutamine sequences released by proteasomes during protein degradationN-linked glycosylation does not impair proteasomal degradation but affects class I major histocompatibility complex presentation.Components of the ubiquitin-proteasome pathway compete for surfaces on Rad23 family proteins.Vitiligo puzzle: the pieces fall in place.Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation.The specificity of trimming of MHC class I-presented peptides in the endoplasmic reticulum.High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cellsRedox modulation of thimet oligopeptidase activity by hydrogen peroxideRecognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients.Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens.Systemic analysis of heat shock response induced by heat shock and a proteasome inhibitor MG132Analysis of mouse brain peptides using mass spectrometry-based peptidomics: implications for novel functions ranging from non-classical neuropeptides to microproteins.The small heat shock protein B8 (HSPB8) confers resistance to bortezomib by promoting autophagic removal of misfolded proteins in multiple myeloma cells.Proteome sampling by the HLA class I antigen processing pathwaySecreted immunodominant Mycobacterium tuberculosis antigens are processed by the cytosolic pathway.Caspases in virus-infected cells contribute to recognition by CD8+ T lymphocytes.HIV-1 envelope resistance to proteasomal cleavage: implications for vaccine induced immune responsesPeptidomic analysis of human cell lines.Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells.The ERAP2 gene is associated with preeclampsia in Australian and Norwegian populations.Targeted delivery of an antigenic peptide to the endoplasmic reticulum: application for development of a peptide therapy for ankylosing spondylitis.Analysis of the role of tripeptidyl peptidase II in MHC class I antigen presentation in vivoMajor source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation.Trypanosoma cruzi infection down-modulates the immunoproteasome biosynthesis and the MHC class I cell surface expression in HeLa cells.The carboxypeptidase ACE shapes the MHC class I peptide repertoireProteasome-independent major histocompatibility complex class I cross-presentation mediated by papaya mosaic virus-like particles leads to expansion of specific human T cells.Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective.Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII.Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.The role of antigen cross-presentation from leukemia blasts on immunity to the leukemia-associated antigen PR1.
P2860
Q21146394-4CF7FBAB-C5C1-4F94-A087-C4771DDE42AEQ26866505-E6838239-2FBB-4CC5-AA76-198801A67A18Q27664273-4BEA1FA8-7718-411A-8779-146CF68D8843Q27667473-0952D6D8-0CF1-47D5-B2AA-4827D66F93E9Q27677415-7A74EF8F-E62F-4789-BFD7-0539F89C59E5Q27691353-5A5D084B-004A-45E3-815F-AC22C8E84F0CQ27934044-EEFBC524-3653-49B3-93A7-06DE762D4264Q28115045-4B692776-56E5-46A2-AF08-8F92D79D6228Q28116400-B93455CE-3806-4D90-9506-307BD153B325Q28245575-443669D8-A0D1-4294-A07F-D097A787686DQ33275164-CF227C61-82AC-446A-9A9B-BB3FC4B71489Q33303325-076792F2-5FBA-4447-8C54-5EC2F1F89D4DQ33317408-6D2C50E9-9C48-47B7-8A5A-E842EA8BFD1BQ33344607-4406809A-357F-423C-9441-4975618FF345Q33728510-DDDFC324-2595-4952-939B-5935B7E0087EQ33791476-D9890349-B3BB-4175-9F27-FE435AF6DC97Q33806895-BD6E6ADD-1F83-4BE1-B90C-273CB32001A0Q33862996-577BDC51-47B2-4AB7-8FF1-0638D6BB0967Q33906726-8067EDAB-FBE2-4C49-AC1C-1F7F7AD8F0A1Q33924181-9BC0AD02-F4B5-4177-A152-79010A264D2CQ33954535-39BBF5E1-69EF-4A80-BA3F-B0534C1A2A79Q33987281-88528A04-28A7-48C2-B998-DA29516946F5Q34227679-C33B4BDA-BEEA-488B-B741-8464133772DBQ34276972-B6E2E8CB-E1FE-44D6-91A3-D4A2D22964CCQ34335032-9E64047E-B95A-4F2C-BF80-E921E1D35A1FQ34368703-1BE52C01-DE74-4A0E-9E25-A17290665D38Q34374375-F4BF0A23-7652-4AC7-8A57-4BD441E6B997Q34756925-CA577924-6EDB-4618-91D1-6D4DA0A3D41AQ34921343-513A316B-F056-41DD-AB04-21C1BEF08EE6Q34990788-292FC386-2BBA-4315-AA20-F13D2E7CAC19Q35025474-93FA3B6C-F0D9-4CEE-B057-96E1D2DF44A6Q35041080-F7DE8897-2E74-470C-90E3-3077DE85880AQ35105327-BD20617B-A9D6-4515-828B-9BF2BA88CD31Q35154144-AA75B05F-8E54-4AAE-AE1E-E4A9EEA1E31CQ35402189-91BFE197-BE30-4EFA-8507-0B8A10B4155DQ35635264-70FFDC70-ECB8-4893-B222-E29F569284C7Q35740189-DF6AB441-2203-48AE-B908-93125E9B3A2CQ35821221-BBD3DE36-D761-4E76-B3A8-97C793A66C5AQ35886450-161D319B-21BE-403A-9BB1-E10959B89E13Q35888562-AC568E10-EC56-45FA-BE79-58CBAFB13AC9
P2860
Post-proteasomal antigen processing for major histocompatibility complex class I presentation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Post-proteasomal antigen proce ...... complex class I presentation.
@ast
Post-proteasomal antigen proce ...... complex class I presentation.
@en
type
label
Post-proteasomal antigen proce ...... complex class I presentation.
@ast
Post-proteasomal antigen proce ...... complex class I presentation.
@en
prefLabel
Post-proteasomal antigen proce ...... complex class I presentation.
@ast
Post-proteasomal antigen proce ...... complex class I presentation.
@en
P2093
P2860
P921
P356
P1433
P1476
Post-proteasomal antigen proce ...... complex class I presentation.
@en
P2093
Alfred L Goldberg
Ian A York
Kenneth L Rock
P2860
P304
P356
10.1038/NI1089
P407
P577
2004-07-01T00:00:00Z